UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Whole-body autoradiography in drug discovery

Current drug metabolism, 2002-10, Vol.3 (5), p.451-462

2002

Volltextzugriff (PDF)

L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase

Antimicrobial Agents and Chemotherapy, 1995-12, Vol.39 (12), p.2602-2605

1995

Volltextzugriff (PDF)

Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor

Drug metabolism and disposition, 1996-03, Vol.24 (3), p.307

1996

Volltextzugriff (PDF)

Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor

Drug metabolism and disposition, 1996-10, Vol.24 (10), p.1111

1996

Volltextzugriff (PDF)

Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans

Drug metabolism and disposition, 1996-12, Vol.24 (12), p.1389

1996

Volltextzugriff (PDF)

Meet the Editorial Board Member

Current drug metabolism, 2022-11, Vol.23 (13), p.1011-1011

Balani, S.K.

2022

Volltextzugriff (PDF)

Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile

Drug metabolism and disposition, 1997-11, Vol.25 (11), p.1282

1997

Volltextzugriff (PDF)

Meet the Editorial Board Member

Current drug metabolism, 2021-04, Vol.22 (5), p.327-327

Balani, S.K.

2021

Volltextzugriff (PDF)

Testing paradigm for prediction of development-limiting barriers and human drug toxicity

Chemico-biological interactions, 2004-11, Vol.150 (1), p.9-25

2004

Volltextzugriff (PDF)

Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine

Drug metabolism and disposition, 1995-02, Vol.23 (2), p.266

1995

Volltextzugriff (PDF)

Nonlinear pharmacokinetics of efavirenz (DMP-266), a potent HIV-1 reverse transcriptase inhibitor, in rats and monkeys

Drug metabolism and disposition, 1999-01, Vol.27 (1), p.41

1999

Volltextzugriff (PDF)

In vitro and in vivo studies on the metabolism of tirofiban

Drug metabolism and disposition, 1999-11, Vol.27 (11), p.1360

1999

Volltextzugriff (PDF)

Disposition of Caspofungin, a Novel Antifungal Agent, in Mice, Rats, Rabbits, and Monkeys

Antimicrobial Agents and Chemotherapy, 2004-04, Vol.48 (4), p.1272-1280

2004

Volltextzugriff (PDF)

Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans

Drug metabolism and disposition, 1997-09, Vol.25 (9), p.1022

1997

Volltextzugriff (PDF)

Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine

Drug metabolism and disposition, 2000-11, Vol.28 (11), p.1274

2000

Volltextzugriff (PDF)

Metabolism of L-689,502 by rat liver slices to potent HIV-1 protease inhibitors

Drug metabolism and disposition, 1995-02, Vol.23 (2), p.185

1995

Volltextzugriff (PDF)

5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase

Journal of medicinal chemistry, 1993-04, Vol.36 (9), p.1291-1294

1993

Volltextzugriff (PDF)

In vitro metabolism of L-696,229, an HIV-1 reverse transcriptase inhibitor in rats and humans. Hepatic and extrahepatic metabolism and identification of enzymes involved in the hepatic metabolism

Drug metabolism and disposition, 1994-03, Vol.22 (2), p.281

1994

Volltextzugriff (PDF)

Metabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices

Drug metabolism and disposition, 1992-11, Vol.20 (6), p.869

1992

Volltextzugriff (PDF)

Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans

Drug metabolism and disposition, 1994-03, Vol.22 (2), p.200

1994

Volltextzugriff (PDF)

Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor

Drug metabolism and disposition, 1993-07, Vol.21 (4), p.598

1993

Volltextzugriff (PDF)

In Vitro Studies on the Metabolic Activation of the Furanopyridine L-754,394, a Highly Potent and Selective Mechanism-Based Inhibitor of Cytochrome P450 3A4

Chemical research in toxicology, 1996-09, Vol.9 (6), p.1007-1012

1996

Volltextzugriff (PDF)

Mutagenicity and tumorigenicity of the four enantiopure bay-region 3,4-diol-1,2-epoxide isomers of dibenz[a,h]anthracene

Carcinogenesis (New York), 2013-09, Vol.34 (9), p.2184-2191

2013

Volltextzugriff (PDF)

Synthesis of enantiomerically pure bay-region 10,11-diol 8,9-epoxide diastereomers of the carcinogen dibenz[a,h]acridine

Journal of organic chemistry, 1992-05, Vol.57 (10), p.2784-2787

1992

Volltextzugriff (PDF)

Tumorigenicity of racemic and optically pure bay region diol epoxides and other derivatives of the nitrogen heterocycle dibenz[a,h]acridine on mouse skin

Carcinogenesis (New York), 2001-06, Vol.22 (6), p.951-955

2001

Volltextzugriff (PDF)

1 – 25 von 261

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(205)
Mit Volltextzugriff
(172)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(260)

Erscheinungsjahr

n.n

Thema

Science & Technology
(162)
Life Sciences & Biomedicine
(79)
Technology
(63)
Humans
(61)
Materials Science
(59)
Male
(53)
Animals
(50)
Biological And Medical Sciences
(48)
Medical Sciences
(45)
Pharmacology & Pharmacy
(45)
Chemistry
(36)
Pharmacology. Drug Treatments
(36)
Physical Sciences
(36)
Female
(33)
Exact Sciences And Technology
(31)
Rats
(29)
Rats, Sprague-Dawley
(23)
Materials Science, Biomaterials
(21)
Materials Science, Multidisciplinary
(20)
Physics
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Whole-body autoradiography in drug discovery

L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase

Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor

Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor

Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans

Meet the Editorial Board Member

Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile

Meet the Editorial Board Member

Testing paradigm for prediction of development-limiting barriers and human drug toxicity

Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine

Nonlinear pharmacokinetics of efavirenz (DMP-266), a potent HIV-1 reverse transcriptase inhibitor, in rats and monkeys

In vitro and in vivo studies on the metabolism of tirofiban

Disposition of Caspofungin, a Novel Antifungal Agent, in Mice, Rats, Rabbits, and Monkeys

Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans

Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine

Metabolism of L-689,502 by rat liver slices to potent HIV-1 protease inhibitors

5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase

In vitro metabolism of L-696,229, an HIV-1 reverse transcriptase inhibitor in rats and humans. Hepatic and extrahepatic metabolism and identification of enzymes involved in the hepatic metabolism

Metabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices

Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans

Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor

In Vitro Studies on the Metabolic Activation of the Furanopyridine L-754,394, a Highly Potent and Selective Mechanism-Based Inhibitor of Cytochrome P450 3A4

Mutagenicity and tumorigenicity of the four enantiopure bay-region 3,4-diol-1,2-epoxide isomers of dibenz[a,h]anthracene

Synthesis of enantiomerically pure bay-region 10,11-diol 8,9-epoxide diastereomers of the carcinogen dibenz[a,h]acridine

Tumorigenicity of racemic and optically pure bay region diol epoxides and other derivatives of the nitrogen heterocycle dibenz[a,h]acridine on mouse skin

Suchergebnisse filtern